# PharmaCyte Biotech, Inc.: Form 8-K, filed Jul 18, 2013

- Company: [PharmaCyte Biotech, Inc.](/companies/pmcb.md) (CIK 1157075)
- Form: 8-K
- Filed: 2013-07-18
- Accepted by EDGAR: Jul 17, 2013, 20:19 ET
- Period: 2013-07-17
- Accession: 0001157075-13-000007
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1157075/000115707513000007/nvlx8kbbbcfoofficers201307.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157075/000115707513000007/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157075/000115707513000007/nvlx8kbbbcfoofficers201307.htm

Filed Jul 18, 2013.
Source: SEC EDGAR, the filing index for accession 0001157075-13-000007. Last ingested by Listed: Nov 14, 2026, 20:52 ET. No prices; not investment advice.
